Skip to main content
Premium Trial:

Request an Annual Quote

Baylor, U Minn, Mayo Adopt Open Biosystems' RNAi Program

NEW YORK (GenomeWeb News) — Open Biosystems yesterday said that three US research centers have adopted its RNAi Program, which gives access to the company’s shRNA libraries, technical support, and access to extensions of existing libraries.
 
Baylor College of Medicine, the University of Minnesota, and the Mayo Clinic will use the Open Biosystems programs in several types of genome studies, the company said.
 
Open Biosystems' portfolio of RNAi resources include shRNAmir lentiviral and retroviral libraries targeting the entire human and mouse genomes, the RNAi Consortium human and mouse lentiviral shRNA libraries, lentiviral inducible shRNAmir library targeting the human genome, and RNAi collections targeting Drosophila, C. elegans, and zebrafish.
 
Financial terms of the agreements were not released.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.